Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta Pharmaceutica Sinica B ; (6): 1885-1902, 2021.
Article Dans Anglais | WPRIM | ID: wpr-888840

Résumé

Multidrug resistance (MDR) mediated by ATP binding cassette subfamily B member 1 (ABCB1) is significantly hindering effective cancer chemotherapy. However, currently, no ABCB1-inhibitory drugs have been approved to treat MDR cancer clinically, mainly due to the inhibitor specificity, toxicity, and drug interactions. Here, we reported that three polyoxypregnanes (POPs) as the most abundant constituents of

2.
Chinese Journal of Cancer ; (12): 419-426, 2013.
Article Dans Anglais | WPRIM | ID: wpr-320581

Résumé

The prognosis of patients diagnosed with hepatocellular carcinoma (HCC) is often dismal, mainly due to late presentation, high recurrence rate, and frequent resistance to chemotherapy and radiotherapy. Accumulating evidence on the differential microRNA (miRNA) expression patterns between non-tumor and HCC tissues or between liver cancer stem cells (CSCs) and non-CSC subsets and the significant clinical implications of these differences suggest that miRNAs are a promising, non-invasive marker for the prognosis and diagnosis of the disease. This perspective article summarizes the current knowledge of miRNAs in liver CSCs and highlights the need for further investigations of the role of miRNAs in regulating liver CSC subsets for possible future clinical applications.


Sujets)
Humains , Marqueurs biologiques tumoraux , Métabolisme , Carcinome hépatocellulaire , Métabolisme , Anatomopathologie , Foie , Métabolisme , Tumeurs du foie , Métabolisme , Anatomopathologie , microARN , Classification , Métabolisme , Cellules souches tumorales , Métabolisme , Pronostic
SÉLECTION CITATIONS
Détails de la recherche